[HTML][HTML] Progress in Dermatology: Cutaneous Oncology in Organ Transplant Recipients: Meeting the Challenge of Squamous Cell Carcinoma
JA Carucci - Journal of investigative dermatology, 2004 - Elsevier
JA Carucci
Journal of investigative dermatology, 2004•ElsevierThe incidence of nonmelanoma skin cancer continues to rise with over 1.3 million cases
diagnosed in the United States in 2002.[1] Squamous cell carcinoma (SCC), the second
most common human cancer, accounts for 250,000 cancers diagnosed in the US annually.
In the majority of cases, cure is achieved, however there are subsets of patients in whom
SCCs behave aggressively and in whom SCC can be devastating.[2] This is particularly true
in the case of organ transplant recipients (OTRs).[3]There are over 100,000 OTRs currently …
diagnosed in the United States in 2002.[1] Squamous cell carcinoma (SCC), the second
most common human cancer, accounts for 250,000 cancers diagnosed in the US annually.
In the majority of cases, cure is achieved, however there are subsets of patients in whom
SCCs behave aggressively and in whom SCC can be devastating.[2] This is particularly true
in the case of organ transplant recipients (OTRs).[3]There are over 100,000 OTRs currently …
The incidence of nonmelanoma skin cancer continues to rise with over 1.3 million cases diagnosed in the United States in 2002.[1] Squamous cell carcinoma (SCC), the second most common human cancer, accounts for 250,000 cancers diagnosed in the US annually. In the majority of cases, cure is achieved, however there are subsets of patients in whom SCCs behave aggressively and in whom SCC can be devastating.[2] This is particularly true in the case of organ transplant recipients (OTRs).[3]
There are over 100,000 OTRs currently living in the United States.[4] Over 25,000 transplants are performed in the US annually with the large majority being renal transplants.[5] Transplant recipients are living longer with the half life of renal grafts reaching 20 years [6., 7.] and the 5–year survival rate for heart transplant recipients approaching 80%.[8]
Elsevier